CTLA4 fusion proteins for the treatment of diabetes

• 收藏
• 分享

专利权人:

DMNoMore

发明人:

ORBAN, Tihamer

申请号：

AU2018201965

公开号：

AU2018201965B2

申请日:

2018.03.20

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

#$%^&*AU2018201965B220191121.pdf#####: amt Interwoven NRPortbl DCC AMT 16669396_l.docx-20/03/2018 ABSTRACT A method of treating, preventing, or delaying the progression of Type 1 diabetes mellitus autoimmunity by administering an effective amount of a cytotoxic T-lymphocyteassociated antigen 4 (CTLA4) molecule is provided herewith. The CTLA4 molecule may be a fusion protein of a CTLA4 extracellular region and an immunoglobulin, such as abatacept.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/